Cleveland HeartLab Inc., a company developing proprietary heart disease tests, has added three executives to its management team.
Deborah H. Sun, Ph.D., has been appointed vice president of laboratory operations. Cleveland HeartLab said Dr. Sun has more than 20 years of experience in the field of clinical laboratory management. She most recently was scientific director of clinical pathology at South Bend Medical Foundation, Sound Bend, Ind., a regional clinical laboratory serving physicians and patients in five states. Dr. Sun earned her Ph.D. in clinical chemistry from Cleveland State University.
Cory Bystrom, Ph.D., has been appointed director of research and development. Dr. Bystrom brings more than a decade of experience as a laboratory leader and chemist to his new role. He joins the company from Quest Diagnostics Nichols Institute, San Juan Capistrano, Calif., where he was associate director of research and development.
“The addition of Dr. Deborah Sun and Dr. Cory Bystrom to the Cleveland HeartLab team will expand and accelerate our continuing efforts to develop and commercialize proprietary tests based on significant, unmet needs in the market,” said Jake Orville, president and CEO of Cleveland HeartLab. “Their experience developing important new tests and overseeing their scale-up to commercialization will be invaluable to us as Cleveland HeartLab continues to establish itself as a preeminent specialty clinical laboratory and disease management company.”
Also, Cleveland HeartLab announced that Stephen A. Massaro has been appointed vice president of sales. Mr. Massaro brings over twenty years of sales management experience to the company. He most recently was area vice president of sales for Smiths Medical, a provider of medical devices.